ckd-349
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 26, 2021 (NCT04676893)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05189288 | Phase 1 | Jan 14, 2022 | Chong Kun Dang Pharmaceutical |
| NCT05089279 | Phase 1 | Oct 20, 2021 | Chong Kun Dang Pharmaceutical |
| NCT04952506 | Phase 1 | Jun 30, 2021 | Chong Kun Dang Pharmaceutical, Chungnam National University |
| NCT04676893 | Phase 1 | Feb 26, 2021 | Chong Kun Dang Pharmaceutical |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | For profit | 4 | 4 | 1 | 2021 |
| Chungnam National University | Academic/Hospital | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1